Skip Header

Contribute Send feedback
Read comments (?) or add your own

P08246 (ELNE_HUMAN) Reviewed, UniProtKB/Swiss-Prot

Last modified January 25, 2012. Version 135. Feed History...

Clusters with 100%, 90%, 50% identity | Documents (7) | Third-party data text xml rdf/xml gff fasta
to top of pageNames·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize order

Names and origin

Protein namesRecommended name:
Neutrophil elastase

EC=3.4.21.37
Alternative name(s):
Bone marrow serine protease
Elastase-2
Human leukocyte elastase
Short name=HLE
Medullasin
PMN elastase
Gene names
Name:ELANE
Synonyms:ELA2
OrganismHomo sapiens (Human)
Taxonomic identifier9606 [NCBI]
Taxonomic lineageEukaryotaMetazoaChordataCraniataVertebrataEuteleostomiMammaliaEutheriaEuarchontogliresPrimatesHaplorrhiniCatarrhiniHominidaeHomo

Protein attributes

Sequence length267 AA.
Sequence statusComplete.
Sequence processingThe displayed sequence is further processed into a mature form.
Protein existenceEvidence at protein level

General annotation (Comments)

Function

Modifies the functions of natural killer cells, monocytes and granulocytes. Inhibits C5a-dependent neutrophil enzyme release and chemotaxis. Ref.15

Catalytic activity

Hydrolysis of proteins, including elastin. Preferential cleavage: Val-|-Xaa > Ala-|-Xaa.

Subunit structure

Interacts with NOTCH2NL. Ref.16

Tissue specificity

Bone marrow cells.

Involvement in disease

Defects in ELANE are a cause of cyclic haematopoiesis (CH) [MIM:162800]; also known as cyclic neutropenia. CH is an autosomal dominant disease in which blood-cell production from the bone marrow oscillates with 21-day periodicity. Circulating neutrophils vary between almost normal numbers and zero. During intervals of neutropenia, affected individuals are at risk for opportunistic infection. Monocytes, platelets, lymphocytes and reticulocytes also cycle with the same frequency. Ref.16 Ref.21

Defects in ELANE are the cause of neutropenia severe congenital autosomal dominant type 1 (SCN1) [MIM:202700]. SCN1 is a disorder of hematopoiesis characterized by a maturation arrest of granulopoiesis at the level of promyelocytes with peripheral blood absolute neutrophil counts below 0.5 x 109/l and early onset of severe bacterial infections. Ref.26

Sequence similarities

Belongs to the peptidase S1 family. Elastase subfamily.

Contains 1 peptidase S1 domain.

Sequence caution

The sequence CAA29300.1 differs from that shown. Reason: Erroneous initiation.

Ontologies

Keywords
   Coding sequence diversityPolymorphism
   DiseaseDisease mutation
   DomainSignal
   Molecular functionHydrolase
Protease
Serine protease
   PTMDisulfide bond
Glycoprotein
Zymogen
   Technical term3D-structure
Complete proteome
Direct protein sequencing
Reference proteome
Gene Ontology (GO)
   Biological processcellular calcium ion homeostasis

Non-traceable author statement Ref.15. Source: UniProtKB

negative regulation of chemokine biosynthetic process

Inferred from direct assay. Source: UniProtKB

negative regulation of chemotaxis

Non-traceable author statement Ref.15. Source: UniProtKB

negative regulation of inflammatory response

Non-traceable author statement Ref.15. Source: UniProtKB

negative regulation of interleukin-8 biosynthetic process

Inferred from direct assay. Source: UniProtKB

positive regulation of MAP kinase activity

Non-traceable author statement. Source: UniProtKB

positive regulation of interleukin-8 biosynthetic process

Inferred from direct assay. Source: UniProtKB

positive regulation of smooth muscle cell proliferation

Inferred from direct assay. Source: UniProtKB

protein catabolic process

Non-traceable author statement. Source: UniProtKB

proteolysis

Inferred from direct assay. Source: MGI

response to UV

Inferred from direct assay. Source: UniProtKB

   Cellular componentcell surface

Inferred from direct assay. Source: UniProtKB

extracellular region

Non-traceable author statement. Source: UniProtKB

secretory granule

Inferred from direct assay. Source: MGI

   Molecular functionbacterial cell surface binding

Non-traceable author statement. Source: UniProtKB

cytokine binding

Inferred from physical interaction. Source: UniProtKB

heparin binding

Inferred from direct assay. Source: MGI

Complete GO annotation...

Sequence annotation (Features)

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifier

Molecule processing

Signal peptide1 – 2727 Potential
Propeptide28 – 292
PRO_0000027703
Chain30 – 267238Neutrophil elastase
PRO_0000027704

Regions

Domain30 – 247218Peptidase S1

Sites

Active site701Charge relay system
Active site1171Charge relay system
Active site2021Charge relay system

Amino acid modifications

Glycosylation881N-linked (GlcNAc...) Ref.17
Glycosylation1241N-linked (GlcNAc...) Ref.8
Glycosylation1731N-linked (GlcNAc...) Ref.8 Ref.17
Disulfide bond55 ↔ 71 Ref.8
Disulfide bond151 ↔ 208 Ref.8
Disulfide bond181 ↔ 187 Ref.8
Disulfide bond198 ↔ 223 Ref.8

Natural variations

Natural variant251A → V in SCN1. Ref.26
VAR_064512
Natural variant321G → V in CH. Ref.21
VAR_009538
Natural variant551C → Y in GFI1. Ref.23
VAR_038609
Natural variant571A → T in GFI1. Ref.22
VAR_038610
Natural variant601I → T in GFI1. Ref.22
VAR_038611
Natural variant711C → R in GFI1. Ref.24
Corresponds to variant rs28931611 [ dbSNP | Ensembl ].
VAR_038612
Natural variant711C → S in GFI1. Ref.22
VAR_038613
Natural variant851G → E in GFI1. Ref.23
VAR_038614
Natural variant981V → L in GFI1; located on the same allele as L-101; reduces proteolytic enzyme activity by slightly less than half; together with L-101 shows an additive effect with minimal remaining enzyme activity. Ref.25
VAR_038615
Natural variant1011V → L in GFI1; located on the same allele as L-98; reduces proteolytic enzyme activity by slightly less than half; together with L-98 shows an additive effect with minimal remaining enzyme activity. Ref.25
VAR_038616
Natural variant1011V → M in GFI1. Ref.22
Corresponds to variant rs28929494 [ dbSNP | Ensembl ].
VAR_038617
Natural variant1231L → PQL in GFI1.
VAR_038618
Natural variant1261S → L in GFI1. Ref.22 Ref.23
VAR_038619
Natural variant1391P → L in GFI1. Ref.22
Corresponds to variant rs28929493 [ dbSNP | Ensembl ].
VAR_038620
Natural variant1511C → S in GFI1. Ref.23
VAR_038621
Natural variant1661A → T in SCN1; the patient also carries mutation Lys-116 in G6PC3. Ref.26
VAR_064513
Natural variant1771V → F in CH. Ref.21
VAR_009539
Natural variant190 – 19910Missing in GFI1.
VAR_038622
Natural variant1911R → Q in CH; loss of interaction with NOTCH2NL and loss of NOTCH2NL and NOTCH2 proteolytic cleavage. Ref.16 Ref.21
VAR_009540
Natural variant2051P → R in GFI1. Ref.23
VAR_038623
Natural variant2101G → V in GFI1. Ref.22
VAR_038624
Natural variant2141G → R in GFI1. Ref.22
VAR_038625
Natural variant2191V → I. Ref.5
Corresponds to variant rs17216656 [ dbSNP | Ensembl ].
VAR_019237
Natural variant2571P → L. Ref.5
Corresponds to variant rs17216663 [ dbSNP | Ensembl ].
VAR_019238
Natural variant2621P → L. Ref.5
Corresponds to variant rs17216670 [ dbSNP | Ensembl ].
VAR_019239

Secondary structure

........................................... 267
Helix Strand Turn

Details...

Sequences

Sequence LengthMass (Da)Tools
P08246 [UniParc].

Last modified August 1, 1988. Version 1.
Checksum: 3F7610DC33CAA4B9

FASTA26728,518
        10         20         30         40         50         60 
MTLGRRLACL FLACVLPALL LGGTALASEI VGGRRARPHA WPFMVSLQLR GGHFCGATLI 

        70         80         90        100        110        120 
APNFVMSAAH CVANVNVRAV RVVLGAHNLS RREPTRQVFA VQRIFENGYD PVNLLNDIVI 

       130        140        150        160        170        180 
LQLNGSATIN ANVQVAQLPA QGRRLGNGVQ CLAMGWGLLG RNRGIASVLQ ELNVTVVTSL 

       190        200        210        220        230        240 
CRRSNVCTLV RGRQAGVCFG DSGSPLVCNG LIHGIASFVR GGCASGLYPD AFAPVAQFVN 

       250        260 
WIDSIIQRSE DNPCPHPRDP DPASRTH 

« Hide

References

« Hide 'large scale' references
[1]"Nucleotide sequence of human bone marrow serine protease (medullasin) gene."
Nakamura H., Okano K., Aoki Y., Shimizu H., Naruto M.
Nucleic Acids Res. 15:9601-9601(1987) [PubMed: 3479752] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA].
[2]"Structure of the human neutrophil elastase gene."
Takahashi H., Nukiwa T., Yoshimura K., Quick C.D., States D.J., Holmes M.D., Whang-Peng J., Knutsen T., Crystal R.G.
J. Biol. Chem. 263:14739-14747(1988) [PubMed: 2902087] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA].
[3]"The human neutrophil elastase gene. Analysis of the nucleotide sequence reveals three distinct classes of repetitive DNA."
Farley D., Travis J., Salvesen G.
Biol. Chem. Hoppe-Seyler 370:737-744(1989) [PubMed: 2775493] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA].
[4]"Functional expression of human leukocyte elastase (HLE)/medullasin in eukaryotic cells."
Okano K., Aoki Y., Shimizu H., Naruto M.
Biochem. Biophys. Res. Commun. 167:1326-1332(1990) [PubMed: 2322278] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA].
[5]NIEHS SNPs program
Submitted (APR-2004) to the EMBL/GenBank/DDBJ databases
Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANTS ILE-219; LEU-257 AND LEU-262.
[6]"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."
The MGC Project Team
Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
Tissue: Lung.
[7]"Molecular cloning of complementary DNA for human medullasin: an inflammatory serine protease in bone marrow cells."
Okano K., Aoki Y., Sakurai T., Kajitani M., Kanai S., Shimazu T., Shimizu H., Naruto M.
J. Biochem. 102:13-16(1987) [PubMed: 2822677] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 30-267.
[8]"Primary structure of human neutrophil elastase."
Sinha S., Watorek W., Karr S., Giles J., Bode W., Travis J.
Proc. Natl. Acad. Sci. U.S.A. 84:2228-2232(1987) [PubMed: 3550808] [Abstract]
Cited for: PROTEIN SEQUENCE OF 30-247.
[9]Travis J., Giles P.J., Porcelli L., Reilly C.F., Baugh R., Powers J.
(In) Protein degradation in health and disease, Ciba Foundation Symposium, pp.75:51-68, Excerpta Medica, Amsterdam and Oxford (1980)
Cited for: PRELIMINARY PROTEIN SEQUENCE OF 30-103.
[10]"Antibiotic proteins of human polymorphonuclear leukocytes."
Gabay J.E., Scott R.W., Campanelli D., Griffith J., Wilde C., Marra M.N., Seeger M., Nathan C.F.
Proc. Natl. Acad. Sci. U.S.A. 86:5610-5614(1989) [PubMed: 2501794] [Abstract]
Cited for: PROTEIN SEQUENCE OF 30-49.
[11]"Use of proteinase 3 purified by reverse phase HPLC to detect autoantibodies in systemic vasculitis."
Gaskin G., Kendal H., Coulthart A., Turner N., Pusey C.D.
J. Immunol. Methods 180:25-33(1995) [PubMed: 7897245] [Abstract]
Cited for: PROTEIN SEQUENCE OF 30-49.
Tissue: Neutrophil.
[12]"Myelomonocytic cell lineage expression of the neutrophil elastase gene."
Takahashi H., Nukiwa T., Basset P., Cystal R.G.
J. Biol. Chem. 263:2543-2547(1988) [PubMed: 3422232] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 75-267.
[13]"Molecular cloning of human neutrophil elastase."
Farley D., Salvesen G.S., Travis J.
Biol. Chem. Hoppe-Seyler 369:3-7(1988) [PubMed: 2462434] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 123-267.
[14]"The primary structure and elastinolytic activity of medullasin (a serine protease of bone marrow)."
Aoki Y., Hase T.
Biochem. Biophys. Res. Commun. 178:501-506(1991) [PubMed: 1859409] [Abstract]
Cited for: PROTEIN SEQUENCE OF 262-267.
[15]"Human leukocyte elastase and cathepsin G are specific inhibitors of C5a-dependent neutrophil enzyme release and chemotaxis."
Tralau T., Meyer-Hoffert U., Schroder J.M., Wiedow O.
Exp. Dermatol. 13:316-325(2004) [PubMed: 15140022] [Abstract]
Cited for: FUNCTION.
[16]"A novel notch protein, N2N, targeted by neutrophil elastase and implicated in hereditary neutropenia."
Duan Z., Li F.-Q., Wechsler J., Meade-White K., Williams K., Benson K.F., Horwitz M.
Mol. Cell. Biol. 24:58-70(2004) [PubMed: 14673143] [Abstract]
Cited for: INTERACTION WITH NOTCH2NL, CHARACTERIZATION OF VARIANT CH GLN-191.
[17]"Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry."
Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.
J. Proteome Res. 8:651-661(2009) [PubMed: 19159218] [Abstract]
Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-88 AND ASN-173, MASS SPECTROMETRY.
Tissue: Liver.
[18]"Structure of human neutrophil elastase in complex with a peptide chloromethyl ketone inhibitor at 1.84-A resolution."
Navia M.A., McKeever B.M., Springer J.P., Lin T.-Y., Williams H.R., Fluder E.M., Dorn C.P., Hoogsteen K.
Proc. Natl. Acad. Sci. U.S.A. 86:7-11(1989) [PubMed: 2911584] [Abstract]
Cited for: X-RAY CRYSTALLOGRAPHY (1.84 ANGSTROMS).
[19]"The refined 2.3-A crystal structure of human leukocyte elastase in a complex with a valine chloromethyl ketone inhibitor."
Wei A.-Z., Mayr I., Bode W.
FEBS Lett. 234:367-373(1988) [PubMed: 3391280] [Abstract]
Cited for: X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS).
[20]"X-ray crystal structure of the complex of human leukocyte elastase (PMN elastase) and the third domain of the turkey ovomucoid inhibitor."
Bode W., Wei A.-Z., Huber R., Meyer E., Travis J., Neumann S.
EMBO J. 5:2453-2458(1986) [PubMed: 3640709] [Abstract]
Cited for: X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS).
[21]"Mutations in ELA2, encoding neutrophil elastase, define a 21-day biological clock in cyclic haematopoiesis."
Horwitz M., Benson K.F., Person R.E., Aprikyan A.G., Dale D.C.
Nat. Genet. 23:433-436(1999) [PubMed: 10581030] [Abstract]
Cited for: VARIANTS CH VAL-32; PHE-177 AND GLN-191.
[22]"Mutations in the gene encoding neutrophil elastase in congenital and cyclic neutropenia."
Dale D.C., Person R.E., Bolyard A.A., Aprikyan A.G., Bos C., Bonilla M.A., Boxer L.A., Kannourakis G., Zeidler C., Welte K., Benson K.F., Horwitz M.
Blood 96:2317-2322(2000) [PubMed: 11001877] [Abstract]
Cited for: VARIANTS GFI1 THR-57; THR-60; SER-71; MET-101; LEU-126; LEU-139; VAL-210 AND ARG-214.
[23]"Mutations in the ELA2 gene encoding neutrophil elastase are present in most patients with sporadic severe congenital neutropenia but only in some patients with the familial form of the disease."
Ancliff P.J., Gale R.E., Liesner R., Hann I.M., Linch D.C.
Blood 98:2645-2650(2001) [PubMed: 11675333] [Abstract]
Cited for: VARIANTS GFI1 TYR-55; GLU-85; PRO-GLN-LEU-123 INS; LEU-126; SER-151; 190-VAL--PHE-199 DEL AND ARG-205.
[24]"Paternal mosaicism proves the pathogenic nature of mutations in neutrophil elastase in severe congenital neutropenia."
Ancliff P.J., Gale R.E., Watts M.J., Liesner R., Hann I.M., Strobel S., Linch D.C.
Blood 100:707-709(2002) [PubMed: 12091371] [Abstract]
Cited for: VARIANT GFI1 ARG-71.
[25]"Double de novo mutations of ELA2 in cyclic and severe congenital neutropenia."
Salipante S.J., Benson K.F., Luty J., Hadavi V., Kariminejad R., Kariminejad M.H., Rezaei N., Horwitz M.S.
Hum. Mutat. 28:874-881(2007) [PubMed: 17436313] [Abstract]
Cited for: VARIANTS GFI1 LEU-98 AND LEU-101, CHARACTERIZATION OF VARIANTS GFI1 LEU-98 AND LEU-101.
[26]"Digenic mutations in severe congenital neutropenia."
Germeshausen M., Zeidler C., Stuhrmann M., Lanciotti M., Ballmaier M., Welte K.
Haematologica 95:1207-1210(2010) [PubMed: 20220065] [Abstract]
Cited for: VARIANTS SCN1 VAL-25 AND THR-166.
+Additional computationally mapped references.

Web resources

ELA2base

ELA2 mutation db

GeneReviews
NIEHS-SNPs
Wikipedia

Elastase entry

Cross-references

Sequence databases

EMBL
GenBank
DDBJ
Y00477 Genomic DNA. Translation: CAA68537.1.
M20203 expand/collapse EMBL AC list , M20199, M20200, M20201 Genomic DNA. Translation: AAA36359.1.
M34379 mRNA. Translation: AAA36173.1.
AY596461 Genomic DNA. Translation: AAS89303.1.
BC074816 mRNA. Translation: AAH74816.1.
BC074817 mRNA. Translation: AAH74817.1.
D00187 mRNA. Translation: BAA00128.1.
X05875 mRNA. Translation: CAA29299.1.
X05875 mRNA. Translation: CAA29300.1. Different initiation.
J03545 mRNA. Translation: AAA52378.1.
M27783 mRNA. Translation: AAA35792.1.
IPIIPI00027769.
PIRELHUL. A31976.
RefSeqNP_001963.1. NM_001972.2.
UniGeneHs.99863.

3D structure databases

PDBe
RCSB PDB
PDBj
EntryMethodResolution (Å)ChainPositionsPDBsum
1B0FX-ray3.00A30-247[»]
1H1BX-ray2.00A/B30-247[»]
1HNEX-ray1.84E30-247[»]
1PPFX-ray1.80E30-247[»]
1PPGX-ray2.30E30-247[»]
2RG3X-ray1.80A30-247[»]
2Z7FX-ray1.70E30-247[»]
3Q76X-ray1.86A/B30-247[»]
3Q77X-ray2.00A30-247[»]
ProteinModelPortalP08246.
SMRP08246. Positions 30-247.
ModBaseSearch...

Protein-protein interaction databases

IntActP08246. 1 interaction.
STRINGP08246.

Protein family/group databases

MEROPSS01.131.

Polymorphism databases

DMDM119292.

Proteomic databases

PeptideAtlasP08246.
PRIDEP08246.

Protocols and materials databases

StructuralBiologyKnowledgebaseSearch...

Genome annotation databases

EnsemblENST00000263621; ENSP00000263621; ENSG00000197561.
GeneID1991.
KEGGhsa:1991.
UCSCuc002lqb.1. human.

Organism-specific databases

CTD1991.
GeneCardsGC19P000852.
H-InvDBHIX0040125.
HGNCHGNC:3309. ELANE.
HPACAB015409.
MIM130130. gene.
162800. phenotype.
202700. phenotype.
neXtProtNX_P08246.
Orphanet486. Autosomal dominant severe congenital neutropenia.
2686. Cyclic neutropenia.
PharmGKBPA165393391.
PA27735.
GenAtlasSearch...

Phylogenomic databases

eggNOGprNOG08661.
GeneTreeENSGT00580000081367.
HOGENOMHBG755338.
HOVERGENHBG013304.
InParanoidP08246.
OMAWINSIIR.
OrthoDBEOG4XSKQQ.
PhylomeDBP08246.

Enzyme and pathway databases

BRENDA3.4.21.37. 2681.
Pathway_Interaction_DBamb2_neutrophils_pathway. amb2 Integrin signaling.

Gene expression databases

ArrayExpressP08246.
BgeeP08246.
CleanExHS_ELA2.
GenevestigatorP08246.
GermOnlineENSG00000197561. Homo sapiens.

Family and domain databases

InterProIPR009003. Pept_cys/ser_Trypsin-like.
IPR018114. Peptidase_S1/S6_AS.
IPR001254. Peptidase_S1_S6.
IPR001314. Peptidase_S1A.
[Graphical view]
KOK01327.
PfamPF00089. Trypsin. 1 hit.
[Graphical view]
PRINTSPR00722. CHYMOTRYPSIN.
SMARTSM00020. Tryp_SPc. 1 hit.
[Graphical view]
SUPFAMSSF50494. Pept_Ser_Cys. 1 hit.
PROSITEPS50240. TRYPSIN_DOM. 1 hit.
PS00134. TRYPSIN_HIS. 1 hit.
PS00135. TRYPSIN_SER. 1 hit.
[Graphical view]
ProtoNetSearch...

Other

DrugBankDB00058. Alpha-1-proteinase inhibitor.
DB00099. Filgrastim.
DB00019. Pegfilgrastim.
NextBio8051.
SOURCESearch...

Entry information

Entry nameELNE_HUMAN
AccessionPrimary (citable) accession number: P08246
Secondary accession number(s): P09649, Q6B0D9, Q6LDP5
Entry history
Integrated into UniProtKB/Swiss-Prot: August 1, 1988
Last sequence update: August 1, 1988
Last modified: January 25, 2012
This is version 135 of the entry and version 1 of the sequence. [Complete history]
Entry statusReviewed (UniProtKB/Swiss-Prot)
Annotation programChordata Protein Annotation Program
DisclaimerAny medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care.

Relevant documents

Peptidase families

Classification of peptidase families and list of entries

Human chromosome 19

Human chromosome 19: entries, gene names and cross-references to MIM

Human entries with polymorphisms or disease mutations

List of human entries with polymorphisms or disease mutations

Human polymorphisms and disease mutations

Index of human polymorphisms and disease mutations

MIM cross-references

Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot

PDB cross-references

Index of Protein Data Bank (PDB) cross-references

SIMILARITY comments

Index of protein domains and families